PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.35
Bid: 8.20
Ask: 8.50
Change: -0.25 (-2.91%)
Spread: 0.30 (3.659%)
Open: 8.50
High: 8.50
Low: 8.35
Prev. Close: 8.60
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agronomics Welcomes Marisa Drew as a Director

23 Feb 2023 07:00

RNS Number : 6296Q
Agronomics Limited
23 February 2023
 

23 February 2023

 

Agronomics Limited

 

("Agronomics" or the "Company")

 

Agronomics Welcomes Marisa Drew to the Board of Directors

Agronomics (ANIC:LSE), the leading listed company focused on the field of cellular agriculture is pleased to announce that it has today appointed Marisa Drew as an Independent Non-Executive Director. Marisa Drew is the inaugural Chief Sustainability Officer ("CSO") of Standard Chartered Bank Plc, responsible for setting the bank's sustainability strategy and the delivery of the firm's commitment to net zero carbon emissions by 2050 as well as overseeing the sustainable finance client-facing activities of the bank. Prior to this, she held the CSO role at Credit Suisse as well as being CEO of the Sustainability Strategy, Advisory & Finance Group. Marisa also Co-Chaired the Sustainability Leaders Committee, served on the ESG Steering Committee, the Climate Risk Strategy Steering Committee, and the UK Reputational Risk Committee of the bank. Marisa also sits on the member of the UK Financial Conduct Authority's Markets Practitioner Panel and has served on several High Level Working Groups ("HLG") sponsored by the World Economic Forum and the UN, including as co-chair of the HLG for Humanitarian Aid and the Oceans Panel.

As a globally recognised leader in sustainability, Marisa brings a vast wealth of experience to the Board and is thoroughly aligned with Agronomics' mission of bringing sustainable alternatives to agricultural products to consumers by investing in leading cellular agriculture companies.

Marisa Drew, Non-Executive Director of Agronomics commented: -

"I am delighted to be joining the Board of Agronomics at this truly exciting time in the field of cellular agriculture. Over the past year, Agronomics has grown its portfolio and is investing in ground-breaking companies and technologies creating a more sustainable protein production system. I look forward to working with my fellow board members to support the growth of the portfolio companies and scaling of the industry."

Jim Mellon, Co-Founder and Executive Director of Agronomics commented: -

"It is a pleasure to welcome Marisa to Agronomics' Board of Directors. Marisa brings with her a wealth of experience, particularly in the sphere of sustainability, and has a track record of achieving investor returns in her previous roles. As a recognised leader in sustainability, Marisa will be well equipped to work with Agronomics' senior team to enhance its portfolio and help advance the prospects for the field of cellular agriculture."

Marisa Danielle Drew (aged 58) is or has during the last five years been a director or partner of the following companies and partnerships:

Current:

Past:

Liberty Global PLC

Sunrise Communications Group AG

Cash & Rocket Holdings Ltd

Aspen Institute UK

 

 

Marisa Drew is also on the Advisory Boards of the Financial Conduct Authority (Expert Markets Practitioners Advisory Panel), The City of London Corporation and Room to Read, an education charity, and was on the Advisory Board at The Wharton School (EMEA Countries Advisory Board) until 2022.

 

Other than as disclosed above, there are no further disclosures to be made in accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord

Genuity Limited

Cenkos

Securities Plc

Peterhouse Capital

Limited

 

TB Cardew

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Richard Reed

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Rees

Alex Aylen 

(Head of Equities)

Giles Balleny

Max Gould

Michael Johnson

Lucy Williams

Charles Goodfellow

 Ed Orlebar

Alistair Walker

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

 

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWFUFEDSEDE
Date   Source Headline
9th Dec 20207:00 amRNSInvestment in CellX
7th Dec 20201:00 pmRNSPortfolio Update: Mosa Meat
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO
1st Apr 20207:00 amRNSFurther investment in Rebellyous Foods
31st Mar 202010:56 amRNSSubscription of US$2,999,996 in Tropic Biosciences
13th Mar 20207:00 amRNSPortfolio Company Update: Foods United
10th Mar 20207:00 amRNSInvestment of US$ 500,000 in GALY CO.
27th Feb 20207:00 amRNSPortfolio Company BlueNalu Announces Financing
13th Feb 20207:00 amRNSAdditional Investment of US$1 Million in VitroLabs
12th Feb 20207:00 amRNSInvestment of US$3million in Foods United
4th Feb 20201:04 pmRNSResult of AGM
31st Jan 20204:42 pmRNSHolding(s) in Company
28th Jan 20203:58 pmRNSHolding(s) in Company
24th Jan 20201:00 pmRNSFurther Equity Fundraise of £5.5 million
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSHalf-year Report
27th Dec 201912:30 pmRNSIssue of Equity
20th Dec 20197:00 amRNSInvestment in Meatable BV
19th Dec 20197:00 amRNSAdditional Participation in BlueNalu Fundraise
18th Dec 20197:00 amRNSInvestment in LegenDairy Foods GmbH
16th Dec 20194:02 pmRNSHolding(s) in Company
16th Dec 20193:33 pmRNSHolding(s) in Company
12th Dec 20196:01 pmRNSHolding(s) in Company
11th Dec 201912:00 pmRNSInvestment in Oritain Global Limited
9th Dec 20193:00 pmRNSEquity Fundraise Closes at £7.7 million
6th Dec 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.